RPID: Rapid Micro Biosystems Company Buyout Price

Symbol and logo of brand rapidmicrobio.com (RPID)

The price action history of Rapid Micro Biosystems (RPID) demonstrates an Enterprise Value of 43.07. Business success depends on pharmaceutical behemoths implementing automation in microbiological surveillance and adhering to sterility standards. The company is currently scaling its innovations, replacing manual labor with high-precision solutions. Revenue is generated through the supply of diagnostic systems and the steady sale of ancillary consumables for quality control.

RPID rapidmicrobio.com: Enterprise Value in the range 11/23/2025 - 10/28/2026

Rapid Micro Biosystems, Inc. (RPID) - metric breakdowns and financial figures

- price and consensus price forecast:
Quote Chart Rapid Micro Biosystems Inc.|RPID - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Rapid Micro Biosystems|RPID - Enterprise Value
- book capitalization data:
Equity per Share Rapid Micro Biosystems|RPID - Book Capitalization|Capitalization to Book Value Ratio rapidmicrobio.com|RPID - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Rapid Micro Biosystems|RPID - Long-Term Debt to Capital|Short-Term Debt to Capital Rapid Micro Biosystems Inc.|RPID - Company Aggregate Debts|Debt to Net Assets Rapid Micro Biosystems
Summary company analysis:Rapid Micro Biosystems (RPID)
Original product of Rapid Micro Biosystems, Inc.

Enterprise value combines market capitalization with net debt, reflecting the total acquisition cost of a business inclusive of all liabilities and liquid assets. The enterprise value trend allows for an assessment of the investment attractiveness of Rapid Micro Biosystems (RPID), considering the costs of automating microbiological control and the development of partnerships with pharmaceutical behemoths while scaling their joint monitoring protocols.

Competitor analysis

Full Business Value Abbott Labs ABT|Enterprise Value TMO (Thermo Fisher Corp)|GEHC - Company Buyout Price|Enterprise Value Mettler-Toledo International|waters.com (WAT) - Business Value|Enterprise Value Bio-Techne (TECH)|Business Value Bruker Corp|AZTA (Azenta Life Sciences) - Enterprise Value|Company Buyout Price Varex Imaging Corp. (VREX)|Enterprise Value SMLR (Semler Scientific, Inc.)|Enterprise Value butterflynetwork.com BFLY|Enterprise Value MLAB|QSI: Full Takeover Company Value|Total Company Value Nanox|QTRX (Quanterix Inc) - Business Value|Total Company Value MASS (908 Devices Inc.)|Total Enterprise Value CV|MXCT (MaxCyte) - Total Company Value|Company Buyout Price Seer Inc SEER|Real Price to Acquire Entire Company Hyperfine Corp (HYPR)|Aggregate Business Value FONAR Corporation Inc FONR|Enterprise Value DXR (Daxor Corp.)|MDAI - Company Buyout Price|VIVS (Organovo Holdings Inc.) - Enterprise Value|Real Price to Acquire Entire Company Aclarion Inc|AKYA - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash THMO|Total Company Value TLIS (Talis Biomedical)|Real Price to Acquire Entire Company t2biosystems.com (TTOO)